AU461935B2 - Contraceptive method and compositions - Google Patents
Contraceptive method and compositionsInfo
- Publication number
- AU461935B2 AU461935B2 AU33806/71A AU3380671A AU461935B2 AU 461935 B2 AU461935 B2 AU 461935B2 AU 33806/71 A AU33806/71 A AU 33806/71A AU 3380671 A AU3380671 A AU 3380671A AU 461935 B2 AU461935 B2 AU 461935B2
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- contraceptive method
- contraceptive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003433 contraceptive agent Substances 0.000 title 1
- 230000002254 contraceptive effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1426670A CH538283A (en) | 1970-09-25 | 1970-09-25 | Contraceptive product contng progestin and progestagen - for oral administration |
| CHCH14266/70 | 1970-09-25 | ||
| CH1252471 | 1971-08-26 | ||
| CHCH12524/71 | 1971-08-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU3380671A AU3380671A (en) | 1973-03-29 |
| AU461935B2 true AU461935B2 (en) | 1975-06-12 |
Family
ID=25710428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU33806/71A Expired AU461935B2 (en) | 1970-09-25 | 1971-09-22 | Contraceptive method and compositions |
Country Status (10)
| Country | Link |
|---|---|
| AT (1) | AT320138B (en) |
| AU (1) | AU461935B2 (en) |
| BE (1) | BE773064A (en) |
| CA (1) | CA962595A (en) |
| DE (1) | DE2146239A1 (en) |
| ES (1) | ES395365A1 (en) |
| FR (1) | FR2107969B1 (en) |
| GB (1) | GB1369061A (en) |
| IL (1) | IL37765A (en) |
| NL (1) | NL7113201A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA939565B (en) † | 1993-12-21 | 1994-08-11 | Applied Analytical Ind Inc | Method for preparing low dose pharmaceutical products. |
-
1971
- 1971-09-16 DE DE19712146239 patent/DE2146239A1/en active Pending
- 1971-09-21 FR FR7133886A patent/FR2107969B1/fr not_active Expired
- 1971-09-22 IL IL37765A patent/IL37765A/en unknown
- 1971-09-22 CA CA123,417A patent/CA962595A/en not_active Expired
- 1971-09-22 AU AU33806/71A patent/AU461935B2/en not_active Expired
- 1971-09-22 GB GB4416371A patent/GB1369061A/en not_active Expired
- 1971-09-23 ES ES395365A patent/ES395365A1/en not_active Expired
- 1971-09-24 NL NL7113201A patent/NL7113201A/xx unknown
- 1971-09-24 AT AT828971A patent/AT320138B/en not_active IP Right Cessation
- 1971-09-24 BE BE773064A patent/BE773064A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1369061A (en) | 1974-10-02 |
| ES395365A1 (en) | 1974-07-16 |
| AT320138B (en) | 1975-01-27 |
| IL37765A0 (en) | 1972-02-29 |
| NL7113201A (en) | 1972-03-28 |
| CA962595A (en) | 1975-02-11 |
| FR2107969A1 (en) | 1972-05-12 |
| IL37765A (en) | 1975-03-13 |
| DE2146239A1 (en) | 1972-03-30 |
| FR2107969B1 (en) | 1975-04-18 |
| BE773064A (en) | 1972-03-24 |
| AU3380671A (en) | 1973-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA941259A (en) | Cleansing compositions and method | |
| AU448307B2 (en) | Flavoring compositions and processes | |
| AU3040571A (en) | Novel processes and compositions | |
| AU1314370A (en) | Gas-releasable and foamable compositions | |
| AU456072B2 (en) | Photoconductive composition and method | |
| CA966007A (en) | Flavoring processes and compositions | |
| CA978956A (en) | Oxycyclic flavoring compositions and processes | |
| AU3054371A (en) | Keratinolytic compositions and method | |
| AU3132071A (en) | Process and compositions | |
| AU462092B2 (en) | Method of contraception and compositions used therein | |
| AU461935B2 (en) | Contraceptive method and compositions | |
| CA964008A (en) | Dye compositions and method | |
| AU3040771A (en) | Compositions and process | |
| CA850726A (en) | Molding composition and method | |
| CA857843A (en) | Metal-disintegrating composition and method | |
| AU467573B2 (en) | Pharmaceutical compositions and method | |
| CA852227A (en) | Compositions and process | |
| CA851164A (en) | Pharmaceutical composition and method | |
| CA857851A (en) | Pharmaceutical composition and method | |
| AU442094B2 (en) | Pharmaceutical compositions and methods | |
| CA834209A (en) | Benzo-beta-naphthoisospiropyrans and compositions comprising same | |
| CA847305A (en) | Etching methods and composition | |
| AU459801B2 (en) | Preparation and method for contraception | |
| AU457779B2 (en) | Composition and process | |
| AU3263271A (en) | Compositions and processes |